Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bredberg, J. Gobom, A. C. Almstrand, P. Larsson, A. C. Olin, E. Mirgorodskaya (Sweden). Proteomic analysis of exhaled endogenous particles non-invasively sampled from the airways. Eur Respir J 2010; 36: Suppl. 54, 3840

Member's Comments

No comment yet.

Related content which might interest you: Analysis of SpA in exhaled particles Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases Year: 2010 Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 237s Year: 2004 Airway cytokine expression measured by protein array in exhaled breath condensate: correlation with physiological properties in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 External validation of exhaled breath molecular profiling in identifying COPD and asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Source: Eur Respir J 2011; 37: 468 Year: 2011 Differential measurement of exhaled breath temperature allows characterization of the spread of inflammation in airways diseases Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases Year: 2010 A new approach for exhaled breath condensate analysis by calculating the release of mediators per minute, standardised for the total water vapour in exhaled air Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Source: Eur Respir J 2012; 39: 59-66 Year: 2012 TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Source: Eur Respir J 2011; 39: 59-66 Year: 2012 Comparison of mediator levels in exhaled breath condensate obtained through tracheostomy or orally Source: Eur Respir J 2003; 22: Suppl. 45, 293s Year: 2003 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007